Bipartite vectors for co-expression of a growth factor cDNA and short hairpin RNA against an apoptotic gene

Journal of Gene Medicine

Volumn 11, Issue 9, 2009, Pages 764-771

  Li, Feng ^a   Mahato, Ram I ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

iNOS; Islet transplantation; RNAi vectors; shRNA; VEGF

Indexed keywords

BIPARTATE PLASMID VECTOR; COMPLEMENTARY DNA; INDUCIBLE NITRIC OXIDE SYNTHASE; MICRORNA; PLASMID VECTOR; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE EXPRESSION; GENE INSERTION; GENE SILENCING; HUMAN; HUMAN CELL; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PROMOTER REGION; RNA SEQUENCE;

APOPTOSIS; BASE SEQUENCE; CELL LINE; CYTOMEGALOVIRUS; DNA PRIMERS; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE SILENCING; GENETIC VECTORS; HUMANS; MOLECULAR SEQUENCE DATA; NITRIC OXIDE SYNTHASE TYPE II; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

CYTOMEGALOVIRUS;

EID: 70349512724     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1357     Document Type: Article

References (38)

1. Montgomery MK, Xu S, Fire A. RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans. Proc Natl Acad Sci USA 1998; 95: 15502-15507.
2. McCaffrey AP, Meuse L, Pham TT, et al. RNA interference in adult mice. Nature 2002; 418: 38-39.
3. Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806-811.
4. Lee YS, Nakahara K, Pham JW, et al. Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways. Cell 2004; 117: 69-81.
5. Carmell MA, Zhang L, Conklin DS, et al. Germline transmission of RNAi in mice. Nat Struct Biol 2003; 10: 91-92.
6. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550-553.
7. Chen Y, Mahato RI. siRNA pool targeting different sites of human hepatitis B surface antigen efficiently inhibits HBV infection. J Drug Target 2008; 16: 140-148.
8. Dorsett Y, Tuschl T. siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov 2004; 3: 318-329.
9. Li F, Mahato RI. iNOS gene silencing prevents inflammatory cytokine-induced beta-cell apoptosis. Mol Pharm 2008; 5: 407-417.
10. De Paula D, Bentley MV, Mahato RI. Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting. RNA 2007; 13: 431-456.
11. Cheng G, Zhu L, Mahato RI. Caspase-3 gene silencing for inhibiting apoptosis in insulinoma cells and human islets. Mol Pharm 2008; 5: 1093-1102.
12. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-238.
13. Goss JA, Schock AP, Brunicardi FC, et al. Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center. Transplantation 2002; 74: 1761-1766.
14. Berney T, Ricordi C. Islet cell transplantation: the future? Langenbecks Arch Surg 2000; 385: 373-378.
15. Narang AS, Mahato RI. Biological and biomaterial approaches for improved islet transplantation. Pharmacol Rev 2006; 58: 194-243.
16. Panakanti R, Mahato RI. Bipartite vector encoding hVEGF and hIL-1Ra for ex vivo transduction into human islets. Mol Pharm 2009; 6: 274-284.
17. Jia X, Cheng K, Mahato RI. Coexpression of vascular endothelial growth factor and interleukin-1 receptor antagonist for improved human islet survival and function. Mol Pharm 2007; 4: 199-207.
18. Mountford PS, Smith AG. Internal ribosome entry sites and dicistronic RNAs inmammalian transgenesis. Trends Genet 1995; 11: 179-184.
19. Mahato RI, Lee M, Han S, et al. Intratumoral delivery of p2CMVmIL-12 using water-soluble lipopolymers. Mol Ther 2001; 4: 130-138.
20. Mizuguchi H, Xu Z, Ishii-Watabe A, et al. IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther 2000; 1: 376-382.
21. Cai X, Hagedorn CH, Cullen BR. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 2004; 10: 1957-66.
22. Chung KH, Hart CC, Al-Bassam S, et al. Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/ miR-155. Nucleic Acids Res 2006; 34: E53.
23. Zhu X, Santat LA, Chang MS, et al. A versatile approach to multiple gene RNA interference using microRNA-based short hairpin RNAs. BMC Mol Biol 2007; 8: 98.
24. Samakoglu S, Lisowski L, Budak-Alpdogan T, et al. A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference. Nat Biotechnol 2006; 24: 89-94.
25. Boden D, Pusch O, Silbermann R, et al. Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins. Nucleic Acids Res 2004; 32: 1154-1158.
26. Silva JM, Li MZ, Chang K, et al. Second-generation shRNA libraries covering the mouse and human genomes. Nat Genet 2005; 37: 1281-1288.
27. Li L, Lin X, Khvorova A, et al. Defining the optimal parameters for hairpin-based knockdown constructs. RNA 2007; 13: 1765-1774.
28. Grimm D, Kay MA. Combinatorial RNAi: a winning strategy for the race against evolving targets? Mol Ther 2007; 15: 878-888.
29. Stegmeier F, Hu G, Rickles RJ, et al. A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. Proc Natl Acad Sci USA 2005; 102: 13212-13217.
30. Wang L, Mu FY. A Web-based design center for vector-based siRNA and siRNA cassette. Bioinformatics 2004; 20: 1818-1820.
31. Reynolds A, Leake D, Boese Q, et al. Rational siRNA design for RNA interference. Nat Biotechnol 2004; 22: 326-330.
32. Ui-Tei K, Naito Y, Takahashi F, et al. Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. Nucleic Acids Res 2004; 32: 936-948.
33. Wang CY, Li F, Yang Y, et al. Recombinant baculovirus containing the diphtheria toxin a gene for malignant glioma therapy. Cancer Res 2006; 66: 5798-5806.
34. Liu BH, Yang Y, Paton JF, et al. GAL4-NF-kappaB fusion protein augments transgene expression from neuronal promoters in the rat brain. Mol Ther 2006; 14: 872-882.
35. Ong ST, Li F, Du J, et al. Hybrid cytomegalovirus enhancer-h1 promoter-based plasmid and baculovirus vectors mediate effective RNA interference. Hum Gene Ther 2005; 16: 1404-1412.
36. Boudreau RL, Martins I, Davidson BL. Artificial MicroRNAs as siRNA Shuttles: Improved Safety as Compared to shRNAs in vitro and in vivo. Mol Ther 2008.
37. Boudreau RL, Monteys AM, Davidson BL. Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAs. RNA 2008; 14: 1834-1844.
38. Qiu L, Wang H, Xia X, et al. A construct with fluorescent indicators for conditional expression of miRNA. BMC Biotechnol 2008; 8: 77.